WASHINGTON (dpa-AFX) - BioMarin Pharmaceutical Inc. (BMRN) said Tuesday that it has appointed Dan Spiegelman as Executive Vice President and Chief Financial Officer.
Spiegelman will replace longtime BioMarin CFO, Jeffrey Cooper, at the end of the month.
Spiegelman most recently served as a consultant to provide strategic financial management support to a portfolio of public and private life science companies. He is a member of the board of directors at several companies including Affymax, Inc. and Oncothyreon Inc.
From 1998 to 2009, Spiegelman served as Senior Vice President and Chief Financial Officer of CV Therapeutics. From 1991 to 1998, Mr. Spiegelman served various roles at Genentech, Inc., most recently as Treasurer.
Copyright RTT News/dpa-AFX
© 2012 AFX News
